January 05, 2026

Preoperative PAXG vs mFOLFIRINOX in Pancreatic Ductal Adenocarcinoma

As reported in The Lancet by Reni et al, analysis of the first randomization in an Italian 2 × 2 factorial phase III trial (PACT-21 CASSANDRA) has shown better event-free survival with preoperative PA...

The ASCO Post

January 02, 2026

Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable HCC

The expanded indication marks the first and only radioembolization therapy in the United States approved to treat both unresectable hepatocellular carcinoma (HCC) and colorectal cancer liver metastase...

The ASCO Post

December 15, 2025

Phase III Trial Shows No Oncologic Benefit From Routine Preoperative MRI for Some Early Breast Cancers

Rates of local regional recurrence were very low for patients with early-stage triple-negative or HER2-positive breast cancer regardless of whether or not they received a breast MRI for staging and su...

The ASCO Post

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 09, 2025

Study Identifies Rectal Bleeding as Key Predictor of Early-Onset Colorectal Cancer

In individuals younger than age 50 undergoing a colonoscopy, greater odds for having colorectal cancer were observed among those who presented with rectal bleeding, according to findings from a study ...

The ASCO Post

December 04, 2025

Why Patients Who Need a Lung Transplant Are Often Referred Too Late

A lung transplant expert explains why many doctors wait too long to get their patients onto a transplant waiting list.

Keck Medicine of USC

December 03, 2025

Perspectives on Design, Material, and Outcomes in Trifocal IOL

Dr. Neel Desai and Dr. Andrzej Dmitriew discuss how optical design and material composition contribute to patients’ satisfaction with their IOLs

The Ophthalmologist

December 03, 2025

What Africa Taught Me About Vitreoretinal Surgery: Part Two

The mark of any good surgeon is the ability to adapt to their environment

The Ophthalmologist

December 01, 2025

Pushing Boundaries in TMVR

In modern structural heart disease management, the abundance of therapeutic options can be both liberating and paralyzing. When multiple comorbidities converge in a single patient, decisions become exponentially more complex.

Baptist Health South Florida